Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR

AIDS

Volumn 12, Issue 12, 1998, Pages 1419-1425

  Ishikawa, Koichi ^a   Fransen, Katrien ^a   Ariyoshi, Koya ^b   Nkengasong, John N ^c   Janssens, Wouter ^a   Heyndrickx, Leo ^a   Whittle, Hilton ^b   Diallo, Mamadou O ^c   Ghys, Peter D ^a,c   Coulibaly, Issa Malick ^d   Greenberg, Alan E ^c,e   Piedade, Jao ^f   Canas Ferreira, Wanda ^f   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c Projet RETROCI   (Côte d’Ivoire)

^d Prog Natl de Lutte contre le SIDA   (Côte d’Ivoire)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Dual seroreactivity; HIV 2; PCR; West Africa

Indexed keywords

EPITOPE; GAG PROTEIN; POL PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; COTE D'IVOIRE; GAMBIA; GUINEA-BISSAU; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

DNA PRIMERS; DNA, VIRAL; FEMALE; GAMBIA; GENES, ENV; GENES, GAG; GENES, POL; HIV LONG TERMINAL REPEAT; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROVIRUSES; SENSITIVITY AND SPECIFICITY;

EID: 15144357227     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00003     Document Type: Article

References (42)

1. Whittle H, Morris J, Todd J, et al.: HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994, 8:1617-1620.
2. De Cock KM, Odehouri K, Colebunders RL, et al.: A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Côte d'Ivoire. AIDS 1990, 4:443-448.
3. De Cock KM, Adjorlolo G, Ekpini E, et al.: Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993, 270:2083-2086 [Erratum JAMA 1994, 271:196].
4. Diallo MO, Ackah AN, Lafontaine MF, et al.: HIV-1 and HIV-2 infections in men attending sexually transmitted disease clinics in Abidjan, Côte d'Ivoire. AIDS 1992, 6:581-585.
5. George JR, Ou CY, Parekh B, et al.: Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire. Lancet 1992, 340:337-339.
6. Grez M, Dietrich U, Balfe P, et al.: Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1994, 68:2161-2168.
7. Ghys PD, Diallo MO, Ettiegne-Traore V, et al.: Dual seroreactivity to HIV-1 and HIV-2 in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1995, 9:955-958.
8. Hishida O, Ayisi NK, Aidoo M, et al.: Serological survey of HIV-1, HIV-2 and human T-cell leukemia virus type 1 for suspected AIDS cases in Ghana. AIDS 1994, 8:1257-1261.
9. N'Gbichi JM, De Cock KM, Batter V, et al.: HIV status of female sex partners of men reactive to HIV-1, HIV-2 or both viruses in Abidjan, Côte d'Ivoire. AIDS 1995, 9:951-954.
10. Odehouri K, De Cock KM, Krebs JW, et al.: HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire. AIDS 1989, 3:509-512.
11. Pfutzner A, Dietrich U, von Eichel U, et al.: HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. J Acquir Immune Defic Syndr 1992, 5:972-977.
12. Poulsen AG, Aaby P, Larsen O, et al.: 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 1997, 349:911-914.
13. Rubsamen-Waigmann H, Briesen HV, Maniar JK, Rao PK, Scholz C, Pfutzner A: Spread of HIV-2 in India. Lancet 1991, 337:550-551.
14. Soriano V, Gutierrez M, Caballero E, et al.: Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group. Eur J Clin Microbiol Infect Dis 1996, 15:383-388.
15. Matheron S, Mendoza-Sassi G, Simon F, et al.: HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS 1997, 11:934-936.
16. Marlink R, Kanki P, Thior I, et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590.
17. Pepin J, Morgan G, Dunn D, et al.: HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 1991, 5:1165-1172.
18. Travers K, Mboup S, Marlink R, et al.: Natural protection against HIV-1 infection provided by HIV-2. Science 1995, 268:1612-1615 [published erratum appears in Science 1995, 268:1833].
19. Ariyoshi K, Schim van der Loeff M, Sabally S, et al.: Does HIV-2 infection provide cross-protection against HIV-1 infection? [letter]. AIDS 1997, 11:1053-1054.
20. Aaby P, Poulsen AG, Larsen O, et al.: Does HIV-2 protect against HIV-1 infection? AIDS 1997, 11:939-940.
21. Travers KU, Eisen GE, Marlink RG, et al.: Protection from HIV-1 infection by HIV-2 [letter]. AIDS 1998, 12:224-225.
22. Peeters M, Fransen K, Gershy-Damet GM, et al.: Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire. J Virol Methods 1994, 48:23-30.
23. Peeters M, Gershy-Damet GM, Fransen K, et al.: Virological and polymerase chain reaction studies of HIV-1/H1V-2 dual infection in Côte d'Ivoire. Lancet 1992, 340:339-340.
24. Leonard G, Chaput A, Courgnaud V, Sangare A, Denis F, Brechot C: Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993, 7:1185-1189.
25. Evans LA, Moreau J, Odehouri K, et al.: Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 1988, ii: 1389-1391.
26. Gao F, Yue L, Robertson DL, et al.: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994, 68:7433-7447.
27. Chen Z, Luckay A, Sodora DL, et al.: Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 1997, 71:3953-3960.
28. Myers G, Korber B, Hahn B, et al.: Human Retroviruses and AIDS. Los Alamos: Los Alamos National Laboratory, Theoretical Biology and Biophysics Group; 1995.
29. Dieng Sarr A, Hamel DJ, Thior I, et al.: HIV-1 and HIV-2: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998, 12:131-137
30. Janssens W, Heyndrickx L, Fransen K, et al.: Genetic and phylogenetic analysis of env subtypes G and H in Central Africa [letter]. AIDS 1994, 10:877-879.
31. Janssens W, Heyndrickx L, Van de Peer Y, et al.: Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS 1994, 8:21-26.
32. Nyambi P, Willems B, Janssens W, et al.: The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses 1997, 13:7-17.
33. Peeters M, Janssens W, Fransen K, et al.: Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses 1994, 10:1289-1294.
34. Nkengasong J, Maurice C, Koblavi S, et al.: Field evaluation of a combination of monospecific enzyme-linked immunosorbent assays for type-specific diagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV-seropositive persons in Abidjan, Côte d'Ivoire. J Clin Microbiol 1998, 36:123-127.
35. Fransen K, Zhong P, De Beenhouwer H, et al.: Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1994, 8:317-322 [(Erratum Mol Cell Probes 1995, 9:373].
36. Chys PD, Fransen K, Diallo MO, et al.: The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997, 11:F85-F93.
37. Berry N, Ariyoshi K, Jobe O, et al.: HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994, 10:1031-1037.
38. Ariyoshi K, Berry N, Wilkins A, et al.: A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis 1996, 173:245-248.
39. Weiss RA, Clapham PR, Weber JN, et al.: HIV-1 antisera cross-neutralize HIV-1. AIDS 1988, 2:95-100.
40. Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995, 1:59-64.
41. Lee TH, el-Amad Z, Reis M, et al.: Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction. AIDS 1991, 5:1201-1207.
42. Simon F, Matheron S, Tamalet C, et al.: Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.